Tumor-Targeting Ability of Novel Anti-Prostate-Specific Membrane Antigen Antibodies

[Image: see text] Patients with prostate-specific membrane antigen (PSMA)-positive tumors can benefit from PSMA-targeted therapy; thus, we have constructed a phage-displayed synthetic antibody library for the production of novel PSMA antibodies with superior PSMA-targeting ability, favoring clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Hsin-Hua, Kuo, Wei-Ying, Lin, Jia-Jia, Chen, Hong-Sen, Hsu, Hung-Ju, Wu, Chun-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454275/
https://www.ncbi.nlm.nih.gov/pubmed/36092556
http://dx.doi.org/10.1021/acsomega.2c04230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454275/
https://www.ncbi.nlm.nih.gov/pubmed/36092556
http://dx.doi.org/10.1021/acsomega.2c04230

Ejemplares similares